AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
62.72
+0.35 (0.57%)
At close: Mar 23, 2026, 4:00 PM EDT
62.72
0.00 (0.00%)
After-hours: Mar 23, 2026, 4:52 PM EDT
AnaptysBio Employees
AnaptysBio had 104 employees as of December 31, 2025. The number of employees decreased by 32 or -23.53% compared to the previous year.
Employees
104
Change (1Y)
-32
Growth (1Y)
-23.53%
Revenue / Employee
$2,255,798
Profits / Employee
-$127,231
Market Cap
1.80B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 104 | -32 | -23.53% | 104 | 0 |
| Dec 31, 2024 | 136 | 19 | 16.24% | 136 | 0 |
| Dec 31, 2023 | 117 | 21 | 21.88% | 117 | 0 |
| Dec 31, 2022 | 96 | -6 | -5.88% | 96 | 0 |
| Dec 31, 2021 | 102 | 8 | 8.51% | 102 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Ascentage Pharma Group International | 605 |
| Recursion Pharmaceuticals | 600 |
| Ocular Therapeutix | 325 |
| Zymeworks | 264 |
| Relay Therapeutics | 192 |
| Soleno Therapeutics | 182 |
| Aurinia Pharmaceuticals | 128 |
ANAB News
- 13 days ago - AnaptysBio, Inc. (ANAB) Presents at Barclays 28th Annual Global Healthcare Conference Transcript - Seeking Alpha
- 20 days ago - Anaptys Provides Update on Business Separation and Announces Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 26 days ago - Vanda Pharmaceuticals Announces FDA Acceptance of Biologics License Application Filing for Imsidolimab for the Treatment of Generalized Pustular Psoriasis - PRNewsWire
- 6 weeks ago - Anaptys Announces Participation at Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - AnaptysBio, Inc. (ANAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - AnaptysBio seeks partial dismissal in GSK oncology unit dispute over drug royalty - Reuters
- 2 months ago - Anaptys Files Motion to Dismiss Tesaro's Claim of Anticipatory Breach of Contract in Ongoing Litigation Against Tesaro, a GSK subsidiary - GlobeNewsWire
- 2 months ago - Anaptys to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire